Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer
Yapeng Su(Collaborative Innovation Center of Chemical Science and Engineering Tianjin), Wei Wei(Institute for Systems Biology), Alphonsus H. C. Ng(University of Toronto), Dazy Johnson(University of California, Los Angeles), Shiqun Shao(Zhejiang University of Science and Technology), James R. Heath(California Institute of Technology), Guangrong Qin(Institute for Systems Biology), David Baltimore(California Institute of Technology), Songming Peng, Charles Warden(City Of Hope National Medical Center), Yin Tang, Ilya Shmulevich(University of Southern California), Yu Xu(Wuhan University), Jie Chen(Nanjing Maternity and Child Health Care Hospital), J. Lee(California Institute of Technology), R. D. Levine(University of California, Los Angeles), Min Xue(Anhui Medical University), Stephanie Wong(National Center for Infectious Diseases), Antoni Ribas(University of California, Los Angeles), Zhuo Wang(Shanghai Jiao Tong University), Qihui Shi(Fudan University), Jun Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiang Lu(University of California, Los Angeles), Victoria Liu(California Institute of Technology), Hanjun Cheng(Institute for Systems Biology), Jinhui Wang(City of Hope), Yan Kong(Peking University), Raymond T. Ng(BC Cancer Agency), Lídia Robert(University of California, Los Angeles), Guideng Li(California Institute of Technology), Chunmei Liu(Institute for Systems Biology), Xiwei Wu(City Of Hope National Medical Center)
Cited by 15
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.8k
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k